Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

Nature Immunology

Volumn 7, Issue 9, 2006, Pages 929-936

  Batten, Marcel ^a   Li, Ji ^a   Yi, Sothy ^a   Kljavin, Noelyn M ^a   Danilenko, Dimitry M ^a   Lucas, Sophie ^b   Lee, James ^a   de Sauvage, Frederic J ^a   Ghilardi, Nico ^a  

^a GENENTECH INC   (United States)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; EFFECTOR CELL; IMMUNE DEFICIENCY; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL;

ANIMALS; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTORS, CYTOKINE; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA;

EID: 33747588291     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1375     Document Type: Article

References (44)

1. + T cells. Immunity 16, 779-790 (2002).
2. Hibbert, L., Pflanz, S., De Waal Malefyt, R. & Kastelein, R.A. IL-27 and IFN-α signal via STAT1 and STAT3 and induce T-bet and IL-12Rβ2 in naive T cells. J. Interferon Cytokine Res. 23, 513-522 (2003).
3. + T cells through STAT1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100, 15047-15052 (2003).
4. Takeda, A. et al. Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170, 4886-4890 (2003).
5. Chen, Q. et al. Development af Th1-type immune responses requiresthe type I cytokine receptor TCCR. Nature 407, 916-920 (2000).
6. Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231 (2004).
7. Sprecher, C.A. et al. Cloning and characterization of a novel class I cytokine receptor. Biochem. Biophys. Res. Commun. 246, 82-90 (1998).
8. Holscher, C. et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174, 3534-3544 (2005).
9. Pearl, J.E. et al. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J. Immunol. 173, 7490-7496 (2004).
10. Villarino, A. et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19, 645-655 (2003).
11. Yoshida, H. et al. WSX-1 is required for the initiation or Th1 respiinsesand resistance to L. major infection. Immunity 15, 569-578 (2001).
12. Artis, D. et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626-5634 (2004).
13. Hamano, S. et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19, 657-667 (2003).
14. Miyazaki, Y. et al. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J. Immunol. 175, 2401-2407 (2005).
15. Yamanaka, A. et al. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis. J. Immunol. 172, 3590-3596 (2004).
16. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
17. McKenzie, B.S., Kastelein, R.A. & Cua, D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27, 17-23 (2006).
18. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
19. + effector T cells develop via a lineage distinct from the T help type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
20. Infante-Duarte, C., Horton, H.F., Byrne, M.C. & Kamradt, T. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165, 6107-6115 (2000).
21. Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. & Gurney, A.L. Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin 17, J. Biol. Chem. 278, 1910-1914 (2003).
22. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
23. Murphy, C.A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
24. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context at an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity 24. 179-189 (2006).
25. H17 and regulatory T cells. Nature 441, 235-238 (2006).
26. H17 lineage. Nature 441, 231-234 (2006).
27. Villarino, A.V. et al. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176, 237-247 (2006).
28. Owaki, T. et al. IL-27 suppresses CD28-mediated IL-2 production through suppressor of cytokine signaling 3. J. Immmol. 176, 2773-2780 (2006).
29. Bettelli, E. et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79-87 (2004).
30. + T cell-mediated suppression by dendritic cells. Science 299, 1033-1036 (2003).
31. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
32. Sergejeva, S., Ivanov, S., Lotvall, J. & Linden, A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33, 248-253 (2005).
33. McQualter, J.L. et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882 (2001).
34. Samoilova, E.B., Horton, J.L, Hilliard, B., Liu, T.S. & Chen, Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480-6486 (1998).
35. Cho, M.L et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652-5661 (2006).
36. Chen, Z. et al. Selective regulatory function of SOCS3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103, 8137-8142 (2006).
37. Schimpl, A. et al. IL-2 and autoimmune disease. Cytokine Growth Factor Rev. 13, 369-378 (2002).
38. Honda, K. et al, T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm. Bowel Dis. 11, 1044-1052 (2005).
39. Jebbari, H., Roberts, C.W., Ferguson, D.J. Bluethmann, H. & Alexander, J. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 20, 231-239 (1998).
40. Suzuki, Y. et al. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65, 2339-2345 (1997).
41. Gao, W. & Pereira, M.A. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi. Int. J. Parasitol. 32, 167-170 (2002).
42. Kelly, M.N. et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73, 617-621 (2005).
43. Doganci, A., Sauer, K., Karwot, R. & Finotto, S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin. Rev. Allergy Immunol. 28, 257-270 (2005).
44. Sedgwick, J.D. et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88, 7438-7442 (1991).